Medikamentöse Therapie der Obstipation

Conference paper
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Die medikamentöse Therapie der Obstipation datiert bis in die Frühgeschichte der Menschheit. Erste Aufzeichnungen reichen über 4000 Jahre zurück bis in das alte ägyptische Reich. Senna wurde im 9.-10. Jahrhundert durch die Araber in Europa eingeführt, und in der Barockzeit war die Klistierspritze ein Symbol des ärztlichen Standes.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bass P, Dennis S (1981) The laxative effect of lactulose in normal and constipated subjects. J Clin Gastroenterol 3[Suppl 1]:23–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Berclaz R, Miazza BM, Dederding JP, Cunningham M, Loizean E (1988) Wirkung von Cisaprid (Cis) auf die Colon-Passage-Zeit (CTT) bei gesunden Probanden. Gastrointestinale Motilitätsstörungen: Phänomen oder Krankheit? Symposium, 5. März 1988, Wien, Nr 16.Google Scholar
  3. 3.
    Binnie NR, Creasy G, Edmond P, Smith AN (1986) Action of Cisapride on the chronic constipation of paraplegics. Gut 27:A1241.Google Scholar
  4. 4.
    Christensen J, Freeman BW (1972) Circular muscle electromyogramm in cat colon. Local effect of sodium ricinoleate. Gastroenterology 63:1011–1015.PubMedGoogle Scholar
  5. 5.
    Connell AM, Hilton C, Irvine G, Lennard-Jones JF, Misiewicz JJ (1965) Variation in bowel habit in two population samples. Br Med J 2:1095–1099.PubMedCrossRefGoogle Scholar
  6. 6.
    Davis GR, Santa Ana CA, Morawski SG, Fordtran JS (1980) Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology 78:991–995.PubMedGoogle Scholar
  7. 7.
    Ewe K (1979) Der obstipierte Krankenhauspatient. Dtsch Med Wochenschr 104:1254–1255.PubMedCrossRefGoogle Scholar
  8. 8.
    Ewe K (1984) Laxantien,. In: Kümmerle HP, Goossens N (Hrsg) Klinik und Therapie der Nebenwirkungen. Thieme, Stuttgart, S 1018–1027.Google Scholar
  9. 9.
    Ewe K (1986) Laxantienmißbrauch. Internist 27:778–784.PubMedGoogle Scholar
  10. 10.
    Ewe K (1988) Adverse drug reactions in the differential diagnosis of GI and liver disease: diarrhoea and constipation. Baillieres Clin Gastroent 2:353–384.CrossRefGoogle Scholar
  11. 11.
    Ewe K, Goerg KJ (1981) Laxanzien: Wirkungsweise und Nebenwirkungen. Inn Med 8:248–262.Google Scholar
  12. 12.
    Faber P, Strenge-Hesse A (1988) Relevance of rhein excretion into breast milk. Pharmacology 36[Suppl 1]:212–220PubMedCrossRefGoogle Scholar
  13. 13.
    Ferleman G, Vogt W (1965) Entacetylierung und Resorption von phenolischen Laxantien. Naunyn Schmiedebergs Arch Exp Pathol Pharmacol 250:479–487.Google Scholar
  14. 14.
    Fioramonti J, Staumont G, Garcia-Villar R, Bueno L (1988) Effect of sennosides on colon motility in dogs. Pharmacology 36[Suppl 1]:23–30PubMedCrossRefGoogle Scholar
  15. 15.
    Greenhalf JO, Leonhard HSD (1973) Laxatives in the treatment in pregnant and breast-feeding mothers. Practitioner 210:259–263.PubMedGoogle Scholar
  16. 16.
    Kreek MJ, Schäfer RA, Hahn EF, Fischmann J (1983) Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet 1:261–262.PubMedCrossRefGoogle Scholar
  17. 17.
    Krishnamurthy S, Schuffler MS, Rohrmann CA, Pope CE (1985) Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 88:26–34.PubMedGoogle Scholar
  18. 18.
    Lemmli J (1988) Metabolism of sennosides — an overview. Pharmacology 36[Suppl 1]:126–128.CrossRefGoogle Scholar
  19. 19.
    Leng-Peschlow E (1986) Dual effect of orally administered sennosides on large intestine transit and fluid absorption in the rat. J Pharm Pharmacol 38:606–610.PubMedCrossRefGoogle Scholar
  20. 20.
    Levy AG, Benson JW, Hewlett EL et al. (1976) Saline lavage: a rapid effective and acceptable method for cleaning the gastrointestinal tract. Gastroenterology 70:157–161.PubMedGoogle Scholar
  21. 21.
    Marcus SN, Heaton KW (1985) Is “simple constipation” a myth? Gut 26:A571.Google Scholar
  22. 22.
    Marlett JA, Ulyssess B, Li K, Patrow CJ, Bass P (1987) Comperative taxation of psyllium with and without senna in ambulatory population. Am J Gastroenterol 82:333–337.PubMedGoogle Scholar
  23. 23.
    Mengs U (1986) Reproductive toxicological investigations with sennosides. Arzneimittelforsch/Drug Res 36:1355–1358.Google Scholar
  24. 24.
    Müller-Lissner SA (1987) Chronische Obstipation. Dtsch Med Wochenschr 112:1223–1229.PubMedCrossRefGoogle Scholar
  25. 25.
    Müller-Lissner SA, The Bavarian Constipation Study Group (1987) Treatment of chronic constipation with cisapride and placebo. Gut 28:1033–1038.PubMedCrossRefGoogle Scholar
  26. 26.
    Preston DM, Lennard-Jones JE (1985) Pelvic colon motility and response to intraluminal bisacodyl in slow transit constipation. Dig Dis Sci 30:289–294.PubMedCrossRefGoogle Scholar
  27. 27.
    Reboa G, Arnulfo G, Frascio M, Di Somma C, Pitto G, Berti-Riboli E (1984) Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride. Eur J Pharmacol 26:745–748.CrossRefGoogle Scholar
  28. 28.
    Read MG, Read NW, Barber DC, Duthie HL (1982) Effects of loperamide an anal sphincter function in patients complaining of chronic diarrhoea with fecal incontinence and urgency. Dig Dis Sci 27:807–814.PubMedCrossRefGoogle Scholar
  29. 29.
    Riecken EO, Zeitz M, Emde C, Hopert R, Witzel L, Hintze R, Marsch-Ziegler U, Vester JC (1987) Prospective study on the effect of anthrachinone containing laxatives on ultrastructure of colonic nerves. Gastroenterology 92:1595 (abstract).Google Scholar
  30. 30.
    Riemann JF, Schmidt H, Zimmermann W (1980) The fine structure of colonic submucosal nerves in patients with chronic laxative abuse. Scand J Gastroenterol 15:761–768.PubMedCrossRefGoogle Scholar
  31. 31.
    Ritchie J (1972) Mass peristalsis in the human colon after contact with oxyphenisatin. Gut 13:211–219.PubMedCrossRefGoogle Scholar
  32. 32.
    Saunders DR, Sillery J, Rachmilewitz D (1975) Effect of dioctyl sodium sulfosuccinate on structure and function of rodent and human intestine. Gastroenterology 69:380–386.PubMedGoogle Scholar
  33. 33.
    Smith B (1968) Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 9:139–143.PubMedCrossRefGoogle Scholar
  34. 34.
    Staumont G, Frexinos J, Fioramonti J, Bueno L (1988) Sennosides and human colonic motility. Pharmacology 36[Suppl 1]:49–56.PubMedCrossRefGoogle Scholar
  35. 35.
    Sum EA, Snape WJ, Cohen S, Renny A (1982) The role of opiate receptors and cholinergic neurons in the gastrocolonic response. Gastroenterology 82:689–693.Google Scholar
  36. 36.
    Urso FD, Urso MJ, Lee CH (1975) The cathartic colon: pathological findings and radiological pathological correlation. Radiology 116:557–559.PubMedGoogle Scholar
  37. 37.
    Wanitschke R, Ammon HV (1976) Effects of magnesium sulfate on transport in the human jejunum. Gastroenterology 70:949 (abstract).Google Scholar
  38. 38.
    Wanitschke R, Goerg KJ (1985) Abführmittel: Klassifizierung und Wirkungsweise. Arzneimitteltherapie 3:173–177.Google Scholar
  39. 39.
    Wienbeck M, Kartenhaus E, Wallenfels M, Karaus M (1988) Effect of sennosides on colon motility in cats. Pharmacology 36[Suppl 1]:31–39.PubMedCrossRefGoogle Scholar
  40. 40.
    Wittoesch JH, Jackman RJ, McDonald JR (1958) Melanosis coli: general review and study of 887 cases. Dis Colon Rectum 1:172.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • K. Ewe

There are no affiliations available

Personalised recommendations